Market Scenario
Global Body Fat Measurement Market is expected to grow at a CAGR of 9% to reach US$ 1,023.5 million in 2024. The growth rate is coupled with a rising incidence of metabolic disorders and obesity throughout the globe. Unnatural lifestyles such as sedentary routine and excessive fast food consumption are the primary reasons for overweight and obesity. Various instruments are used for measuring the body fat. Muscle to fat ratio analyzers is one of them. These are used for precise assessment of muscle versus body fat. These instruments also analyze health risks associated with high fat in the body. Further, these devices help in evaluating the effectiveness of nutritional intake and exercises done by an individual. Other factors including rising advancements in the BIA devices, expansion process of major players in the international market and rising consciousness regarding increased body weight are also expected to drive the Global Body Fat Measurement Market. According to the World Health Organization (WHO), in 2016, more than 1.9 billion adults across the globe were considered overweight. Of those, over 650 million individuals were suffering from obesity. This trend is more prevalent in developed countries such as U.S., Canada, and U.K. Thus, it is expected to drive the body fat measurement market through the forecast period. In 2017, North America held the highest Global Body Fat Measurement Market share. The market is driven by rising obese population in the U.S. According to CDC report, more than third of the population is obese in the U.S. Further, rising awareness regarding life-threatening conditions associated with obesity such as stroke, diabetes, and heart diseases is also expected to drive the market in North American region. In addition, the presence of a wide target population, increasing awareness regarding fitness and health, and technologically advanced healthcare infrastructure are likely to contribute to the growth of the market in North America. Asia-Pacific is expected to have a higher growth rate in the forecast period. The growth rate is coupled with increasing demand for body fitness in the countries such as Japan and China. Moreover, the presence of a large number of BIA device manufacturers in the region also expected to drive the market through 2024. Bio impedance Analysers (BIA) segment held the highest Global Body Fat Measurement Market share in 2017. The market is primarily driven by continual technical improvements in these devices to address the growing needs of individuals. These devices provide increased accuracy and efficient combination with hydrostatic weighing and callipers and thus, drive the Global Body Fat Measurement Market through the forecast period.
Global Body Fat Measurement Market Segmentation:
• Global Body Fat Measurement Market, By Product
Bio impedance Analyzers (BIA) Body Fat Skinfold Calipers Air Displacement Plethysmography (ADP) Hydrostatic Weighing (HwD) Dual Emission X-Ray Absorptiometry (DEXA) Others The above data will be provided for following regions/countries from 2013-2024 (USD Million) • North America o U.S. o Canada • Europe o Germany o UK o France o Spain o Italy • Asia Pacific o China o India o Japan o Australia • Latin America o Argentina o Brazil o Mexico • Middle East and Africa o South Africa o Saudi Arabia What information is covered in the report? • Actual market numbers from 2013-2017, estimates and forecasts from 2018 to 2024 • Detailed market segmentation and market share analysis of each segment • Impact analysis of various drivers and trends • Market segmentation and landscape • Competitive landscape, 2017 Global Breast Pump Market
Table of Contents
Global Body Fat Measurement Market
Chapter 1 Research Methodology 1.1. Research Methodology 1.2. Market definition 1.3. Assumptions and Acronyms Used 1.4. Data Sources 1.4.1. Secondary 1.4.1.1. Paid 1.4.1.2. Unpaid 1.4.2. Primary Chapter 2 Executive Summary 2.1. Global Body Fat Measurement Market overview 2.1.1. By Products Chapter 3 Global Body Fat Measurement Market Industry Insights 3.1. Market segmentation and scope of study 3.2. Market Drivers and their impact analysis 3.2.1. Market Drivers 3.2.1.1. Growing prevalence of metabolic disorders 3.2.1.2. Increasing rate of obesity 3.2.2. Market Restrains 3.2.2.1. Excessive cost for the equipment’s 3.3. Market share analysis 3.3.1. By Products 3.4. Competitive analysis 3.4.1. Key strategic initiatives 3.4.2. Regional presence 3.4.3. Product overview 3.5. Porter’s analysis 3.6. PESTEL analysis Chapter 4 Body Fat Measurement Market, By Products 4.1. Key segment trends 4.2. Bio Impedance Analyzers (BIA) 4.2.1. Market size, by region, 2013 - 2024 4.3. Body Fat Skinfold Calipers 4.3.1. Market size, by region, 2013 – 2024 4.4. Hydrostatic Weighing (HwD) 4.4.1. Market size, by region, 2013 – 2024 4.5. Air Displacement Plethysmography (ADP) 4.5.1. Market size, by region, 2013 – 2024 4.6. Dual Emission X-ray Absorptiometry (DEXA) 4.6.1. Market size, by region, 2013 – 2024 4.7. Others 4.7.1. Market size, by region, 2013 – 2024 Chapter 5 Body Fat Measurement Market, By Region 5.1. Key regional trends 5.2. North America 5.2.1. Market size, by country, 2013 – 2024 5.2.2. Market size, by products, 2013 – 2024 5.2.3. U.S. 5.2.3.1. Market size, by products, 2013 – 2024 5.2.4. Canada 5.2.4.1. Market size, by products, 2013 – 2024 5.3. Europe 5.3.1. Market size, by country, 2013 – 2024 5.3.2. Market size, by products, 2013 – 2024 5.3.3. Germany 5.3.3.1. Market size, by products, 2013 – 2024 5.3.4. UK 5.3.4.1. Market size, by products, 2013 – 2024 5.3.5. France 5.3.5.1. Market size, by products, 2013 – 2024 5.3.6. Spain 5.3.6.1. Market size, by products, 2013 – 2024 5.3.7. Italy 5.3.7.1. Market size, by products, 2013 – 2024 5.4. Asia Pacific 5.4.1. Market size, by country, 2013 – 2024 5.4.2. Market size, by products, 2013 – 2024 5.4.3. India 5.4.3.1. Market size, by products, 2013 – 2024 5.4.4. China 5.4.4.1. Market size, by products, 2013 – 2024 5.4.5. Japan 5.4.5.1. Market size, by products, 2013 – 2024 5.4.6. Australia 5.4.6.1. Market size, by products, 2013 – 2024 5.5. Latin America 5.5.1. Market size, by country, 2013 – 2024 5.5.2. Market size, by products, 2013 – 2024 5.5.3. Argentina 5.5.3.1. Market size, by products, 2013 – 2024 5.5.4. Brazil 5.5.4.1. Market size, by products, 2013 – 2024 5.5.5. Mexico 5.5.5.1. Market size, by products, 2013 – 2024 5.6. Middle East and Africa 5.6.1. Market size, by country, 2013 – 2024 5.6.2. Market size, by products, 2013 – 2024 5.6.3. South Africa 5.6.3.1. Market size, by products, 2013 – 2024 5.6.4. Saudi Arabia 5.6.4.1. Market size, by products, 2013 – 2024 Chapter 6 Consolidations 6.1. Mergers and Acquisitions 6.2. Partnership, Joint Ventures and Strategic Alliances/Sales Agreements 6.3. Patent Analysis 6.4. Key players 6.4.1. Tanita Corp. 6.4.1.1. Company overview 6.4.1.2. Key financials 6.4.1.3. Product landscape 6.4.1.4. Strategic initiatives 6.4.1.5. SWOT analysis 6.4.2. Omron HCB 6.4.2.1. Company overview 6.4.2.2. Key financials 6.4.2.3. Product landscape 6.4.2.4. Strategic initiatives 6.4.2.5. SWOT analysis 6.4.3. AccuFitness 6.4.3.1. Company overview 6.4.3.2. Key financials 6.4.3.3. Product landscape 6.4.3.4. Strategic initiatives 6.4.3.5. SWOT analysis 6.4.4. Beurer GmbH 6.4.4.1. Company overview 6.4.4.2. Key financials 6.4.4.3. Product landscape 6.4.4.4. Strategic initiatives 6.4.4.5. SWOT analysis 6.4.5. GE Healthcare 6.4.5.1. Company overview 6.4.5.2. Key financials 6.4.5.3. Product landscape 6.4.5.4. Strategic initiatives 6.4.5.5. SWOT analysis 6.4.6. COSMED S.r.l. 6.4.6.1. Company overview 6.4.6.2. Key financials 6.4.6.3. Product landscape 6.4.6.4. Strategic initiatives 6.4.6.5. SWOT analysis 6.4.7. Inbody Co. Ltd. 6.4.7.1. Company overview 6.4.7.2. Key financials 6.4.7.3. Product landscape 6.4.7.4. Strategic initiatives 6.4.7.5. SWOT analysis 6.4.8. Hologic Inc. 6.4.8.1. Company overview 6.4.8.2. Key financials 6.4.8.3. Product landscape 6.4.8.4. Strategic initiatives 6.4.8.5. SWOT analysis 6.4.9. Diagnostic Medical Systems Group 6.4.9.1. Company overview 6.4.9.2. Key financials 6.4.9.3. Product landscape 6.4.9.4. Strategic initiatives 6.4.9.5. SWOT analysis 6.4.10. Exertech 6.4.10.1. Company overview 6.4.10.2. Key financials 6.4.10.3. Product landscape 6.4.10.4. Strategic initiatives 6.4.10.5. SWOT analysis 6.4.11. Jawon Medical Co. Ltd. 6.4.11.1. Company overview 6.4.11.2. Key financials 6.4.11.3. Product landscape 6.4.11.4. Strategic initiatives 6.4.11.5. SWOT analysis 6.4.12. Inbody Co. Ltd. 6.4.12.1. Company overview 6.4.12.2. Key financials 6.4.12.3. Product landscape 6.4.12.4. Strategic initiatives 6.4.12.5. SWOT analysis 6.4.13. L’Accessorio Nucleare S.r.l. 6.4.13.1. Company overview 6.4.13.2. Key financials 6.4.13.3. Product landscape 6.4.13.4. Strategic initiatives 6.4.13.5. SWOT analysis 6.4.14. Wipro 6.4.14.1. Company overview 6.4.14.2. Key financials 6.4.14.3. Product landscape 6.4.14.4. Strategic initiatives 6.4.14.5. SWOT analysis 6.4.15. Veran Medical Technologies 6.4.15.1. Company overview 6.4.15.2. Key financials 6.4.15.3. Product landscape 6.4.15.4. Strategic initiatives 6.4.15.5. SWOT analysis 6.4.16. Boston Scientific Corporation 6.4.16.1. Company overview 6.4.16.2. Key financials 6.4.16.3. Product landscape 6.4.16.4. Strategic initiatives 6.4.16.5. SWOT analysis 6.4.17. MDxHealth 6.4.17.1. Company overview 6.4.17.2. Key financials 6.4.17.3. Product landscape 6.4.17.4. Strategic initiatives 6.4.17.5. SWOT analysis 6.4.18. Mauna Kea Technologies 6.4.18.1. Company overview 6.4.18.2. Key financials 6.4.18.3. Product landscape 6.4.18.4. Strategic initiatives 6.4.18.5. SWOT analysis 6.4.19. Argon Medical Devices, Inc 6.4.19.1. Company overview 6.4.19.2. Key financials 6.4.19.3. Product landscape 6.4.19.4. Strategic initiatives 6.4.19.5. SWOT analysis 6.4.20. Intact Medical Corp. 6.4.20.1. Company overview 6.4.20.2. Key financials 6.4.20.3. Product landscape 6.4.20.4. Strategic initiatives 6.4.20.5. SWOT analysis 6.4.21. Carefusion Corporation 6.4.21.1. Company overview 6.4.21.2. Key financials 6.4.21.3. Product landscape 6.4.21.4. Strategic initiatives 6.4.21.5. SWOT analysis 6.4.22. Devicor Medical Products, Inc. 6.4.22.1. Company overview 6.4.22.2. Key financials 6.4.22.3. Product landscape 6.4.22.4. Strategic initiatives 6.4.22.5. SWOT analysis 6.4.23. DTR Medical 6.4.23.1. Company overview 6.4.23.2. Key financials 6.4.23.3. Product landscape 6.4.23.4. Strategic initiatives 6.4.23.5. SWOT analysis 6.4.24. Cardinal Health Inc. 6.4.24.1. Company overview 6.4.24.2. Key financials 6.4.24.3. Product landscape 6.4.24.4. Strategic initiatives 6.4.24.5. SWOT analysis
